| __timestamp | Bio-Techne Corporation | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 94231000 |
| Thursday, January 1, 2015 | 40853000 | 146394000 |
| Friday, January 1, 2016 | 45187000 | 188272000 |
| Sunday, January 1, 2017 | 53514000 | 166707000 |
| Monday, January 1, 2018 | 55329000 | 401843000 |
| Tuesday, January 1, 2019 | 62413000 | 560909000 |
| Wednesday, January 1, 2020 | 65192000 | 722343000 |
| Friday, January 1, 2021 | 70603000 | 771182000 |
| Saturday, January 1, 2022 | 87140000 | 877090000 |
| Sunday, January 1, 2023 | 92493000 | 877387000 |
| Monday, January 1, 2024 | 96664000 |
Cracking the code
In the competitive world of biotechnology, innovation is the lifeblood of success. Bio-Techne Corporation and Sarepta Therapeutics, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Sarepta Therapeutics consistently outpaced Bio-Techne in R&D spending, with an average annual investment nearly eight times higher. In 2023, Sarepta's R&D expenses reached a staggering 877% of Bio-Techne's, highlighting its commitment to pioneering advancements. However, Bio-Techne has shown a steady increase in its R&D budget, growing by over 200% since 2014. This upward trend underscores its strategic focus on innovation. As we look to the future, the question remains: will Bio-Techne close the gap, or will Sarepta continue to lead the charge in biotech innovation?
Analyzing R&D Budgets: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Bio-Techne Corporation or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Research and Development Investment: Bio-Techne Corporation vs Halozyme Therapeutics, Inc.
R&D Insights: How Bio-Techne Corporation and Grifols, S.A. Allocate Funds
Bio-Techne Corporation vs Xenon Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Bio-Techne Corporation and Agios Pharmaceuticals, Inc.
R&D Spending Showdown: Bio-Techne Corporation vs Vericel Corporation
Research and Development Investment: Sarepta Therapeutics, Inc. vs Verona Pharma plc
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Corcept Therapeutics Incorporated
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.